Special edition of the JAMA Editor's Summary featuring the JAMA Network articles published at the 2025 European Society of Cardiology Congress. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, with JAMA Executive Editor Gregory Curfman, MD, JAMA Senior Editor Philip Greenland, MD, and JAMA Cardiology Editor Robert O. Bonow, MD, MS. Related Content:

Remote Screening for Asymptomatic Atrial Fibrillation
Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation
Systolic Blood Pressure and Microaxial Flow Pump–Associated Survival in Infarct-Related Cardiogenic Shock
Helicobacter pylori Screening After Acute Myocardial Infarction
Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction
Fractional Flow Reserve–Guided Complete vs Culprit-Only Revascularization in Non–ST-Elevation Myocardial Infarction and Multivessel Disease
Transcatheter or Surgical Treatment of Patients With Aortic Stenosis at Low to Intermediate Risk
Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction
Bivalent RSV Prefusion F Protein–Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults
Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine
Clonal Hematopoiesis and Risk of New-Onset Myocarditis and Pericarditis
Participation of Women in Cardiovascular Trials From 2017 to 2023
Prevalence, Determinants, and Time Trends of Cardiovascular Health in the WHO African Region

From the JAMA Network: From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, and more